Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] patient advocates from 13 organizations and 11 nations gathered in Marseille for the first-ever International FSHD Patient Advocacy Summit to discuss global collaboration and coordination. The conference was sponsored by […]
Attendees at our FSHD Family Day conference in Baltimore this past Sunday enjoyed an excellent series of talks by the clinicians and researchers at the Kennedy Krieger Institute. Here are […]
[…] from the FSH Society, a patient-driven nonprofit, has enabled people with facioscapulohumeral muscular dystrophy ( FSHD) to donate muscle tissue, which scientists have succeeded in grafting into mice, providing a […]
 Results presented by Avidity of interim data from its Phase 1/2 clinical trial in FSHD were all the buzz at this year’s International Research Congress and FSHD Connect conference. […]
[…] (RNAi) therapeutic being developed as a potential treatment for patients with facioscapulohumeral muscular dystrophy ( FSHD). ARO-DUX4 is the first clinical candidate utilizing Arrowhead’s proprietary Targeted RNAi Molecule (TRiMTM) platform […]
